STAT: Editorial by Nathan SigworthWhy 2021 is the right time to scale managed entry agreements
STAT: Editorial by Nathan SigworthFour unexpected trends for health care investing in 2021
Vital Health Podcast:PharmaCCX, a tech savvy solution for pricing EU cancer drugs
LIF (Swedish Pharma Association) responded to TLV report expressing a desire to work closely with payers on solving combo oncology challenges
TLV (Sweden) releases report on first negotiation on PharmaCCX Platform
Sweden's vaccine coordinator: It is now the seriousness begins
STAT: Editorial by Nathan SigworthFour reasons you should be optimistic about the future of drug pricing
A video series featuring industry experts and thought leaders at the intersection of technology, healthcare and pharma.